- Technology
- Applications
- Services
- Company
- People
- Board of Directors
- Senior Management
- Larry Gold, Ph.D. - Chairman and CEO
- Bruce Eaton, Ph.D. - Chief Operating Officer
- Scott Kothlow - Chief Financial Officer
- Nebojsa Janjic, Ph.D. - Chief Science Officer
- Nicholas A. Saccamano, Ph.D. - Chief Technology Officer
- Stephen A. Williams, M.D., Ph.D. - Chief Medical Officer
- Steven H. Morrissett, J.D. - Chief Legal Counsel
- Edward N. Brody, M.D., Ph.D. - CMO Emeritus
- Richard M. Lawn, Ph.D. - Executive Director of Translational Medicine
- Advisors
- Recent News
- Press Releases
- 2-17-2102: SOMAscan™ technology presented at 2012 AAAS meeting
- 2-9-2012: SomaLogic receives Gates Foundation TB Grant
- 2-9-2012: SomaLogic scientists to present at Tri-Conference
- 11-29-2011: Agreement for commercial use of Ambergen reagent in SOMAscan™ announced
- 10-18-2011: SomaLogic announces agreement with Novartis to apply technology to R&D
- 7-27-2011: SomaLogic and New England Biolabs Agree on SOMAmer Use in PCR Products
- 12-7-2010: SomaLogic publishes papers describing biomarker technology, application to lung cancer
- 9-3-2010: Emerald and SomaLogic announce collaboration to image SOMAmer-protein complexes
- 8-30-2010: NEC and SomaLogic announce partnership to build health information applications
- 5-9-2008: SomaLogic and Otsuka launch research collaboration on target validation, diagnostics
- 5-6-2005: SomaLogic, Quest Diagnostics to collaborate on clinical diagnostic development
- Press Releases
- Selected Publications
- Patents
- Careers
- Contact Us
- People
- Sitemap
- Online Privacy Policy
- Website Terms of Use